Company / Shareholders' Equity
AtriCure, Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$491.9M
FY2025
5-year range
$456.8M / $491.9M
FY2021-FY2025
Trend
+6.7%
vs FY2024
Sector context
#109 of 166
Health Care
What the data says
At $492M, AtriCure, Inc.'s shareholders' equity ranks #109 of 166 in the Health Care sector. Shareholders' Equity has fluctuated over the past 10 years, ranging from $161M in FY2017 to $492M in FY2025.
Based on SEC 10-K filings.
$492M in FY2025 with a 5-year CAGR of +3.6%.
Improved from $466M to $492M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +2.5%
- 5-Year CAGR
- +3.6%
- 10-Year CAGR
- -
Sector benchmark
#109 of 166 in Health CareTop 66% of 166This company $491.9M Sector average $5.3B
▼
-90.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.6%, indicating consistent growth.
- In FY2025, shareholders' equity increased 6.7% year-over-year.
- Ranks #109 out of 166 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2017.
Company context
Key Data Points
- Negative profit margin: -9.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $491.9M | +6.7% |
| FY2024 | $461.0M | -1.1% |
| FY2023 | $466.2M | +2.1% |
| FY2022 | $456.8M | -5.6% |
| FY2021 | $483.8M | +17.3% |
| FY2020 | $412.4M | +66.7% |
| FY2019 | $247.3M | -0.8% |
| FY2018 | $249.4M | +54.7% |
| FY2017 | $161.2M | -4.3% |
| FY2016 | $168.4M | -9.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026